Accuray (NASDAQ:ARAY) Director Richard Pettingill bought 9,795 shares of Accuray stock on the open market in a transaction dated Tuesday, February 4th. The stock was purchased at an average cost of $10.33 per share, with a total value of $101,182.35. Following the acquisition, the director now directly owns 43,940 shares of the company’s stock, valued at approximately $453,900. Accuray Incorporated (NASDAQ:ARAY) stock opened at $9.64 in last session, and closed at $9.52, while the day range of Accuray Incorporated (NASDAQ:ARAY) stock is $9.42 – $9.65. The stock showed a positive weekly performance of 1.49%.
MELA Sciences, Inc. (NASDAQ:MELA), developer of MelaFind(R) , an FDA approved optical diagnostic device that assists dermatologists in melanoma diagnosis, will release its fourth quarter and full year 2013 results on Monday, March 17, 2014, after the market’s close. MELA Sciences Inc. (NASDAQ:MELA) stock opened at $0.74 in last session, and closed at $0.776 by gaining 5.58%. The 52 week range of $0.63 – $1.39. Company’s market capitalization is $33.63 million.
Ohr Pharmaceutical (NASDAQ:OHRP), a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, and leading global cancer research center Cold Spring Harbor Laboratory (CSHL) announced the establishment of DepYmed Inc., a new joint venture to develop trodusquemine and related analogues. OHR Pharmaceutical Inc. (NASDAQ:OHRP) stock increased 22.02% and finished the last session at $17.73. The EPS of the stock remained -0.27. Company’s market capitalization is $352.35 million.
CEL-SCI Corporation (NYSE:CVM) reported accelerating progress in patient enrolment in the Phase III Head and Neck Cancer clinical trial of its investigational cancer immunotherapy treatment Multikine* (Leukocyte Interleukin, Injection). Approximately 146 patients have been enrolled in the Phase III study to date. CEL-SCI Corporation (NYSEMKT:CVM) stock opened the session at $1.30, and closed the session at $1.41. The 52 week range of the CEL-SCI Corporation (NYSEMKT:CVM) stock remained $0.53 – $3.09 and the day range was $1.30 – $1.52.
Leave a Reply